Baculovirus treatment fully protects mice against a lethal challenge of FMDV

Antiviral Research

Volumn 87, Issue 2, 2010, Pages 276-279

  Molinari, Paula ^a   García Nuñez, Soledad ^a   Gravisaco, M José ^a   Carrillo, Elisa ^a,b   Berinstein, Analía ^a,b   Taboga, Oscar ^a,b  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Baculovirus; FMDV; Mice

Indexed keywords

IMMUNOSTIMULATING AGENT; VIRUS RNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOGRAPHA CALIFORNICA; FEMALE; FOOT AND MOUTH DISEASE VIRUS; IMMUNOSTIMULATION; INNATE IMMUNITY; LETHAL DOSE; MOUSE; NONHUMAN; POLYHEDROSIS VIRUS; PRIORITY JOURNAL; VIREMIA; ANIMAL; BACULOVIRIDAE; BIOLOGICAL THERAPY; C57BL MOUSE; FOOT-AND-MOUTH DISEASE; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INSECT; PATHOLOGY; PROCEDURES; SURVIVAL; VIROLOGY;

ANIMALS; BACULOVIRIDAE; BIOLOGICAL THERAPY; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; INSECTS; MICE; MICE, INBRED C57BL; SURVIVAL ANALYSIS; VIREMIA;

AUTOGRAPHA CALIFORNICA NUCLEOPOLYHEDROVIRUS; BOS; CAPRA HIRCUS; FOOT-AND-MOUTH DISEASE VIRUS; HEXAPODA; MUS; OVIS ARIES; SUIDAE;

EID: 77954957438     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.05.008     Document Type: Article

References (39)

1. Abe T., Hemmi H., Miyamoto H., Moriishi K., Tamura S., Takaku H., Akira S., Matsuura Y. Involvement of the toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J. Virol. 2005, 79:2847-2858.
2. Abe T., Kaname Y., Wen X., Tani H., Moriishi K., Uematsu S., Takeuchi O., Ishii K.J., Kawai T., Akira S., Matsuura Y. Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner. J. Virol. 2009, 83:7629-7640.
3. Abe T., Takahashi H., Hamazaki H., Miyano-Kurosaki N., Matsuura Y., Takaku H. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J. Immunol. 2003, 171:1133-1139.
4. Ahl R., Rump A. Assay of bovine interferons in cultures of the porcine cell line IB-RS-2. Infect. Immun. 1976, 14:603-606.
5. Alves M.P., Guzylack-Piriou L., Juillard V., Audonnet J.C., Doel T., Dawson H., Golde W.T., Gerber H., Peduto N., McCullough K.C., Summerfield A. Innate immune defenses induced by CpG do not promote vaccine-induced protection against foot-and-mouth disease virus in pigs. Clin. Vaccine Immunol. 2009, 16:1151-1157.
6. Ayres M.D., Howard S.C., Kuzio J., Lopez-Ferber M., Possee R.D. The complete DNA sequence of Autographa californica nuclear polyhedrosis virus. Virology 1994, 202:586-605.
7. Bachrach H.L. Foot-and-mouth disease. Annu. Rev. Microbiol. 1968, 22:201-244.
8. Chiang Y.W., Wu J.C., Wang K.C., Lai C.W., Chung Y.C., Hu Y.C. Efficient expression of histidine-tagged large hepatitis delta antigen in baculovirus-transduced baby hamster kidney cells. World J. Gastroenterol. 2006, 12:1551-1557.
9. Chinsangaram J., Koster M., Grubman M.J. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 2001, 75:5498-5503.
10. Chinsangaram J., Moraes M.P., Koster M., Grubman M.J. Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J. Virol. 2003, 77:1621-1625.
11. de Los Santos T., de Avila Botton S., Weiblen R., Grubman M.J. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 2006, 80:1906-1914.
12. García-Nuñez S., König G., Berinstein A., Carrillo E. Differences in the virulence of two strains of foot-and-mouth disease virus serotype A with the same spatiotemporal distribution. Virus Res. 2010, 147:149-152.
13. Golde W.T., Pacheco J.M., Duque H., Doel T., Penfold B., Ferman G.S., Gregg D.R., Rodriguez L.L. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine 2005, 23:5775-5782.
14. Gronowski A.M., Hilbert D.M., Sheehan K.C., Garotta G., Schreiber R.D. Baculovirus stimulates antiviral effects in mammalian cells. J. Virol. 1999, 73:9944-9951.
15. Grubman M.J., Moraes M.P., Diaz-San Segundo F., Pena L., de los Santos T. Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. FEMS Immunol. Med. Microbiol. 2008, 53:8-17.
16. Hamblin C., Kitching R.P., Donaldson A.I., Crowther J.R., Barnett I.T. Enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. III. Evaluation of antibodies after infection and vaccination. Epidemiol. Infect. 1987, 99:733-744.
17. Hervas-Stubbs S., Rueda P., Lopez L., Leclerc C. Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J. Immunol. 2007, 178:2361-2369.
18. Kaikkonen M.U., Räty J.K., Airenne K.J., Wirth T., Heikura T., Yla-Herttuala S. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo. Gene Ther. 2006, 13:304-312.
19. Kamstrup S., Frimann T.H., Barfoed A.M. Protection of Balb/c mice against infection with FMDV by immunostimulation with CpG oligonucleotides. Antiviral Res. 2006, 72:42-48.
20. Kaname Y., Tani H., Kataoka C., Shiokawa M., Taguwa S., Abe T., Moriishi K., Kinoshita T., Matsuura Y. Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64. J. Virol. 2010, 84:3210-3219.
21. Kitajima M., Abe T., Miyano-Kurosaki N., Taniguchi M., Nakayama T., Takaku H. Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus. Mol. Ther. 2008, 16:261-268.
22. Kitajima M., Hamazaki H., Miyano-Kurosaki N., Takaku H. Characterization of baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mammalian cells. Biochem. Biophys. Res. Commun. 2006, 343:378-384.
23. Kitajima M., Takaku H. Induction of antitumor acquired immunity by baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mice. Clin. Vaccine Immunol. 2008, 15:376-378.
24. Knowles N.J., Samuel A.R. Molecular epidemiology of foot-and-mouth disease virus. Virus Res. 2003, 91:65-80.
25. Matsuura Y., Possee R.D., Overton H.A., Bishop D.H. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J. Gen. Virol. 1987, 68(Pt 5):1233-1250.
26. Moraes M.P., Chinsangaram J., Brum M.C., Grubman M.J. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 2003, 22:268-279.
27. Moraes M.P., de Los Santos T., Koster M., Turecek T., Wang H., Andreyev V.G., Grubman M.J. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J. Virol. 2007, 81:7124-7135.
28. O'Reilly D.R., Miller L.K., Luckow V.A. Titering virus stocks. Baculovirus Expression Vectors, A Laboratory Manual 1994, 130-132. W.H. Freeman, New York, NY. D.R. O'Reilly, L.K. Miller, V.A. Luckow (Eds.).
29. Ojala K., Tikka P.J., Kautto L., Käpylä P., Marjomäki V., Oker-Blom C. Expression and trafficking of fluorescent viral membrane proteins in baculovirus-transduced BHK cells. J. Biotechnol. 2004, 114:165-175.
30. Reed L., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493.
31. Rigden R.C., Carrasco C.P., Summerfield A., MCCullough K.C. Macrophage phagocytosis of foot-and-mouth disease virus may create infectious carriers. Immunology 2002, 106:537-548.
32. Rodríguez Pulido M., Sobrino F., Borrego B., Sáiz M. Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3' noncoding region can elicit immunity in swine. J. Virol. 2009, 83:3475-3485.
33. Salguero F.J., Sánchez-Martín M.A., Díaz-San Segundo F., de Avila A., Sevilla N. Foot-and-mouth disease virus (FMDV) causes an acute disease that can be lethal for adult laboratory mice. Virology 2005, 332:384-396.
34. Sanz-Ramos M., Díaz-San Segundo F., Escarmís C., Domingo E., Sevilla N. Hidden virulence determinants in a viral quasispecies in vivo. J. Virol. 2008, 82:10465-10476.
35. Suzuki T., Chang M.O., Kitajima M., Takaku H. Baculovirus activates murine dendritic cells and induces non-specific NK cell and T cell immune responses. Cell Immunol. 2010, 262:35-43.
36. Tami C., Taboga O., Berinstein A., Núñez J.I., Palma E.L., Domingo E., Sobrino F., Carrillo E. Evidence of the coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo. J. Virol. 2003, 77:1219-1226.
37. Tjia S.T., zu Altenschildesche G.M., Doerfler W. Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells. Virology 1983, 125:107-117.
38. Volkman L.E., Goldsmith P.A. In vitro survey of Autographa californica nuclear polyhedrosis virus interaction with nontarget vertebrate host cells. Appl. Environ. Microbiol. 1983, 45:1085-1093.
39. Yang Y., Lo S.L., Yang J., Yang J., Goh S.S., Wu C., Feng S.S., Wang S. Polyethylenimine coating to produce serum-resistant baculoviral vectors for in vivo gene delivery. Biomaterials 2009, 30:5767-5774.